English
 
User Manual Privacy Policy Disclaimer Contact us
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Loss of complex I due to mitochondrial DNA mutations in renal oncocytoma

MPS-Authors
/persons/resource/persons50427

Meierhofer,  David
Mass Spectrometry (Head: David Meierhofer), Scientific Service (Head: Christoph Krukenkamp), Max Planck Institute for Molecular Genetics, Max Planck Society;
Departments of Pediatrics, University Hospital Salzburg, Paracelsus Medical University, Salzburg, Austria;

External Ressource
No external resources are shared
Fulltext (public)

Mayr.pdf
(Publisher version), 349KB

Supplementary Material (public)
There is no public supplementary material available
Citation

Mayr, J. A., Meierhofer, D., Zimmermann, F., Feichtinger, R., Kögler, C., Ratschek, M., et al. (2008). Loss of complex I due to mitochondrial DNA mutations in renal oncocytoma. Clinical Cancer Research, 14(8), 2270-2275. doi:10.1158/1078-0432.CCR-07-4131.


Cite as: http://hdl.handle.net/11858/00-001M-0000-0028-7E67-A
Abstract
Purpose: Many solid tumors exhibit abnormal aerobic metabolism characterized by increased glycolytic capacity and decreased cellular respiration. Recently, mutations in the nuclear encoded mitochondrial enzymes fumarate hydratase and succinate dehydrogenase have been identified in certain tumor types, thus demonstrating a direct link between mitochondrial energy metabolism and tumorigenesis. Although mutations in the mitochondrial genome (mitochondrial DNA, mtDNA) also can affect aerobic metabolism and mtDNA alterations are frequently observed in tumor cells, evidence linking respiratory chain deficiency in a specific tumor type to a specific mtDNA mutation has been lacking. Experimental Design: To identify mitochondrial alterations in oncocytomas, we investigated the activities of respiratory chain enzymes and sequenced mtDNA in 15 renal oncocytoma tissues. Results: Here, we show that loss of respiratory chain complex I (NADH/ubiquinone oxidoreductase) is associated with renal oncocytoma. Enzymatic activity of complex I was undetectable or greatly reduced in the tumor samples (n = 15). Blue Native gel electrophoresis of the multisubunit enzyme complex revealed a lack of assembled complex I. Mutation analysis of the mtDNA showed frame-shift mutations in the genes of either subunit ND1, ND4, or ND5 of complex I in 9 of the 15 tumors. Conclusion: Our data indicate that isolated loss of complex I is a specific feature of renal oncocytoma and that this deficiency is frequently caused by somatic mtDNA mutations.